Clinical Trial Update: Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) [Phase 3]

View source ↗

Summary

Phase 3 trial update for Ferinject in patients with iron deficiency and chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaemia
• Heart Failure
• Iron Deficiency
• Iron Deficiency Anemia

Drugs mentioned

• Ferinject (ferric carboxymaltose)

Snippet

Sponsor: Vifor Pharma | Conditions: Chronic Heart Failure, Iron Deficiency | Phase 3 | Status: COMPLETED